Understanding how to Effectively Monitor AAV Safety in Gene Therapies Employing a Local Route of Administration
Time: 11:30 am
day: Day Two
Details:
• Exploring the differences in how inflammation is tracked locally (eye/ear) compared to systemic ROA
• Delving into the key safety indicators in local delivery of AAV gene therapy
• Reviewing the accuracy of preclinical safety monitoring in locally delivered gene therapies
• Looking to the future of how AAV safety could be tracked for local ROA during the clinical development
